Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "Von Willebrand disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Von Willebrand disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of Biostate® in Children With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
2 Completed Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate®
3 Completed Extension Study of Biostate in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
4 Completed Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: recombinant interleukin-11
5 Terminated A Study With OPTIVATE® in People With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
6 Completed National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Condition: Von Willebrand Disease
Intervention:
7 Terminated
Has Results
IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
8 Recruiting Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
Condition: Von Willebrands Disease
Intervention:
9 Not yet recruiting Molecular and Clinical Profile of Von Willebrand Disease in Spain
Condition: Von Willebrand Disease
Intervention: Genetic: VWF gene analysis
10 Recruiting Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Other: Patients using wilate as standard of care
11 Withdrawn Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention:
12 Recruiting Study of Voncento® in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Voncento
13 Terminated Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
14 Completed Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand Factor (rVWF)
15 Completed A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.
Condition: vonWillebrand's Disease
Interventions: Biological: Optivate® (Human Coagulation Factor VIII);   Biological: Haemate P® (Human Coagulation Factor VIII)
16 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
17 Completed
Has Results
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor (rVWF);   Drug: Placebo;   Biological: Recombinant factor VIIII (rFVIII)
18 Completed
Has Results
IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Oprelvekin, Interleukin 11, IL-11
19 Withdrawn A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Condition: Von Willebrand Disease
Intervention: Drug: ARC1779
20 Completed Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);   Biological: Marketed plasma-derived VWF/FVIII concentrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.